You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Patent: 10,195,266


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,195,266
Title:Versatile influenza virus vaccine composition
Abstract: The present invention relates to a versatile influenza virus vaccine composition using the HA2 helical domain of a hemagglutinin protein, which is an influenza surface protein, and to a pharmaceutical composition for preventing or treating influenza virus infectious diseases. The polypeptide expressed by SEQ ID NO: 3 and the polypeptide expressed by residues 379 to 474 of SEQ ID NO: 1 of the present invention can be mass-produced in E. coli, and effectively produce neutralizing antibodies to various influenza virus subtypes, and thus the polypeptides can be widely utilized as versatile vaccines for influenza virus subtypes and new influenza virus variants.
Inventor(s): Jeong; Dae Gwin (Daejeon, KR), Song; Dae Sub (Sejong, KR), Yoon; Sun Woo (Daejeon, KR)
Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (Daejeon, KR)
Application Number:15/574,274
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Claims and Patent Landscape: A Comprehensive Analysis of US Patent 10,195,266

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. The United States Patent and Trademark Office (USPTO) is at the forefront of this process, evaluating countless patent applications each year. This article delves into the complexities of patent claims and the broader patent landscape, using US Patent 10,195,266 as a case study.

The Importance of Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and the rights granted to the patent holder. The business and legal value of a patent resides primarily in its claims, which must be carefully crafted to ensure they are both valid and enforceable[2].

Types of Patent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These describe a process or method of achieving a particular result.
  • Apparatus Claims: These describe a physical device or system.

The Patent Examination Process

The USPTO's examination process is rigorous and involves several stages:

  • First-Action Allowance Rate: The proportion of applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of applications that produce at least one patent, including outcomes of continuation applications[1].

Challenges in Patent Examination

The increasing number of patent applications and claims complicates the examination process. For instance, the number of claims per patent has risen significantly, with some applications including hundreds or even thousands of claims. This trend is partly due to legal precedents that encourage narrowing amendments to claims during the examination process[2].

The Role of Continuation Applications

Continuation applications allow applicants to pursue additional patents based on an original (progenitor) application. These can include continuations, continuations-in-part, and divisional applications. These procedures can result in multiple patents from a single progenitor application, complicating the calculation of allowance rates[1].

Impact of AI on Patent Applications

The use of AI tools in patent applications is becoming more prevalent, but it also introduces new risks. If AI tools are material to patentability, their use must be disclosed to the USPTO. This includes assessing whether contributions made by AI systems rise to the level of inventorship and ensuring that documents prepared with AI assistance do not introduce inaccurate statements[3].

Cybersecurity Innovations and Patent Landscape

Cybersecurity is a rapidly evolving field with significant investment in research and development. The number of cybersecurity patent applications has accelerated over the past decade, driven by the need for innovative solutions to prevent cyber attacks. The U.S. leads in cybersecurity patent filings, reflecting its large and active cybersecurity workforce[4].

Valuation of Patents

Patents can be valued using several methods:

  • Cost Approach: Based on the cost of developing the patent.
  • Income Approach: Based on the future benefits provided by the patent.
  • Market Approach: Based on what a willing buyer would pay for a similar asset. These methods help in determining the financial value of a patent, which can range from tens of thousands to millions of dollars[5].

Case Study: US Patent 10,195,266

While specific details of US Patent 10,195,266 are not provided here, a comprehensive analysis would involve:

  • Claim Analysis: Reviewing the independent and dependent claims to understand the scope of the invention.
  • Examination History: Analyzing the prosecution history to see how the claims were amended and the interactions with the USPTO.
  • Market Context: Understanding the competitive landscape and how this patent fits into it.
  • Valuation: Applying the cost, income, and market approaches to determine the patent's value.

Claim Analysis

  • Scope and Breadth: Determine if the claims are broad enough to cover the invention but not so broad as to be invalid.
  • Novelty and Non-Obviousness: Ensure the claims meet the criteria of novelty and non-obviousness.

Examination History

  • Office Actions: Review the communications between the applicant and the USPTO to understand any challenges faced during the examination process.
  • Amendments: Analyze any amendments made to the claims and their impact on the patent's scope.

Market Context

  • Competitors: Identify other patents and products in the same field to assess the competitive advantage provided by this patent.
  • Industry Trends: Understand current and future trends in the industry to gauge the patent's potential impact.

Valuation

  • Cost Approach: Calculate the costs incurred in developing the patent, including filing fees, attorney fees, and research costs.
  • Income Approach: Estimate the future income or savings generated by the patent.
  • Market Approach: Compare the patent to similar assets that have been sold or licensed to determine its market value.

Key Takeaways

  • Patent Claims: The claims are crucial in defining the invention and its legal scope.
  • Examination Process: The USPTO's examination process is complex and involves multiple stages and continuation procedures.
  • AI and Patents: The use of AI tools in patent applications must be disclosed and carefully managed to avoid legal issues.
  • Cybersecurity: This field is seeing rapid innovation and a significant increase in patent applications.
  • Valuation: Patents can be valued using cost, income, and market approaches.

FAQs

What is the significance of patent claims in a patent application?

Patent claims define the scope of the invention and the rights granted to the patent holder, making them the most critical part of a patent application.

How does the USPTO handle continuation applications?

The USPTO allows continuation applications, which enable applicants to pursue additional patents based on an original application. These can include continuations, continuations-in-part, and divisional applications.

What are the risks associated with using AI tools in patent applications?

Using AI tools in patent applications requires disclosure to the USPTO if the AI's contributions are material to patentability. There is a risk of inaccurate statements and the need to verify the contributions made by natural persons.

Why is cybersecurity a significant area for patent filings?

Cybersecurity is a rapidly evolving field with a high demand for innovative solutions to prevent cyber attacks. This has led to a significant increase in cybersecurity patent applications over the past decade.

How can the value of a patent be determined?

The value of a patent can be determined using the cost approach (development costs), the income approach (future benefits), and the market approach (comparable sales or licenses).

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. The Yale Journal of Law & Technology.
  2. *US20110138338A1 - Patent Claims Analysis System and Method. Google Patents.
  3. *U.S. Patent Office Issues Additional Guidance on Use of AI Tools. Buchanan Ingersoll & Rooney PC.
  4. *Cybersecurity Innovations And The Patent Landscape. IS Decisions.
  5. *The value of a patent. Perpetual Motion Patents.

More… ↓

⤷  Try for Free

Details for Patent 10,195,266

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Seqirus Vaccines Limited FLUVIRIN influenza virus vaccine Injection 103837 November 03, 1998 10,195,266 2035-05-18
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 December 09, 1999 10,195,266 2035-05-18
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 December 23, 2009 10,195,266 2035-05-18
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 May 09, 2011 10,195,266 2035-05-18
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.